[CR1]
via crossref
|
Angiotensin Receptor Blockade Decreases Markers of Vascular Inflammation
Monika Graninger, Rosemarie Reiter, Christa Drucker, Erich Minar, Bernd Jilma
2004
Journal of Cardiovascular Pharmacology
doi:10.1097/01.fjc.0000137160.76616.cc
pmid:15475831
|
web.archive.org [PDF]
|
[CR2]
via crossref
|
Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1
G Heeba, ME Moselhy, M Hassan, M Khalifa, R Gryglewski, T Malinski
2009
British Journal of Pharmacology
doi:10.1111/j.1476-5381.2009.00125.x
pmcid:PMC2697732
pmid:19226281
|
web.archive.org [PDF]
|
[CR3]
via crossref
|
Interactions Between the Renin-Angiotensin System and Dyslipidemia
Balkrishna M. Singh, Jawahar L. Mehta
2003
Archives of Internal Medicine
doi:10.1001/archinte.163.11.1296
pmid:12796065
|
web.archive.org [PDF]
|
[CR4]
via crossref
|
Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect
D Gómez-Garre, P Muñoz-Pacheco, ML González-Rubio, P Aragoncillo, R Granados, A Fernández-Cruz
2009
British Journal of Pharmacology
doi:10.1111/j.1476-5381.2008.00091.x
pmcid:PMC2697737
pmid:19222481
|
|
[CR5]
via crossref
|
Attenuation of Tissue P-Selectin and MCP-1 Expression and Intimal Proliferation by AT1 Receptor Blockade in Hyperlipidemic Rabbits
H.J. Chen, D.Y. Li, T. Saldeen, M.I. Phillips, J.L. Mehta
2001
Biochemical and Biophysical Research Communications - BBRC
doi:10.1006/bbrc.2001.4590
pmid:11401483
|
|
[CR6]
via crossref
|
In vivo detection of macrophages in a rabbit atherosclerotic model by time-resolved laser-induced fluorescence spectroscopy
Laura Marcu, Qiyin Fang, Javier A. Jo, Thanassis Papaioannou, Amir Dorafshar, Todd Reil, Jian-Hua Qiao, J. Dennis Baker (+ more)
2005
Atherosclerosis
doi:10.1016/j.atherosclerosis.2005.02.010
pmcid:PMC2672099
pmid:16039283
|
web.archive.org [PDF]
|
[CR7]
via crossref
|
Overexpression of ACE2 Enhances Plaque Stability in a Rabbit Model of Atherosclerosis
B. Dong, C. Zhang, J. B. Feng, Y. X. Zhao, S. Y. Li, Y. P. Yang, Q. L. Dong, B. P. Deng (+ more)
2008
Arteriosclerosis, Thrombosis and Vascular Biology
doi:10.1161/atvbaha.108.164715
pmid:18403726
|
web.archive.org [PDF]
|
[CR8]
via crossref
|
Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells
C. Zhang, Y. X. Zhao, Y. H. Zhang, L. Zhu, B. P. Deng, Z. L. Zhou, S. Y. Li, X. T. Lu (+ more)
2010
Proceedings of the National Academy of Sciences of the United States of America
doi:10.1073/pnas.1001253107
pmcid:PMC2936602
pmid:20798044
|
web.archive.org [PDF]
|
[CR9]
via crossref
|
The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients
Seung Hwan Han, Kwang Kon Koh, Michael J. Quon, Yonghee Lee, Eak Kyun Shin
2007
Atherosclerosis
doi:10.1016/j.atherosclerosis.2006.01.021
pmid:16500662
|
|
[CR10]
via crossref
|
Additive Beneficial Effects of Losartan Combined With Simvastatin in the Treatment of Hypercholesterolemic, Hypertensive Patients
K. K. Koh
2004
Circulation
doi:10.1161/01.cir.0000143085.86697.13
pmid:15569835
|
web.archive.org [PDF]
|
[CR11]
via crossref
|
Effect of fluvastatin, lovastatin, nifedipine and verapamil on the systemic exposure of nateglinide in rabbits
Youngmin Kim, Kyemyung Park, Wonku Kang
2010
Biopharmaceutics & drug disposition
doi:10.1002/bdd.724
pmid:20809476
|
|
[CR12]
via crossref
|
Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits
Min-Yu Hu, Yi-Lin Li, Chong-He Jiang, Zhao-Qian Liu, Shu-Lin Qu, Yi-Ming Huang
2008
Nutrition (Burbank, Los Angeles County, Calif.)
doi:10.1016/j.nut.2008.05.006
pmid:18585898
|
|
[CR13]
via crossref
|
Effects of Losartan on expression of connexins at the early stage of atherosclerosis in rabbits
Li-ming Ruan, Wei Cai, Jun-zhu Chen, Jin-feng Duan
2010
International Journal of Medical Sciences
doi:10.7150/ijms.7.82
pmcid:PMC2869452
pmid:20479953
|
web.archive.org [PDF]
|
[CR14]
via crossref
|
Dietary mucilage promotes regression of atheromatous lesions in hypercholesterolemic rabbits
Puthenpura T. Boban, Bala Nambisan, Perumana R. Sudhakaran
2009
Phytotherapy Research
doi:10.1002/ptr.2728
pmid:19107734
|
|
[CR15]
via crossref
|
Cross-talk between dyslipidemia and renin–angiotensin system and the role of LOX-1 and MAPK in atherogenesis
Jiawei Chen, Dayuan Li, Robert Schaefer, Jawahar L. Mehta
2006
Atherosclerosis
doi:10.1016/j.atherosclerosis.2005.04.016
pmid:16005008
|
|
[CR16]
via crossref
|
Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels
Lin Zhong, Wen Qiang Chen, Xiao Ping Ji, Mei Zhang, Yu Xia Zhao, Gui Hua Yao, Peng Fei Zhang, Cheng Zhang (+ more)
2008
Journal of Cellular and Molecular Medicine
doi:10.1111/j.1582-4934.2008.00261.x
pmcid:PMC4514114
pmid:18266972
|
web.archive.org [PDF]
|
[CR17]
via crossref
|
Comparative Effects of ACE Inhibitors and an Angiotensin Receptor Blocker on Atherosclerosis and Vascular Function
Yi-ping Sun, Bo-qing Zhu, Amanda E. M. Browne, Satyavardhan Pulukurthy, Tony M. Chou, Krishnankutty Sudhir, Stanton A. Glantz, Prakash C. Deedwania (+ more)
2001
Journal of Cardiovascular Pharmacology and Therapeutics
doi:10.1177/107424840100600209
pmid:11509924
|
|
[CR18]
via crossref
|
Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques
Yiannis S. Chatzizisis, Michael Jonas, Roy Beigel, Ahmet U. Coskun, Aaron B. Baker, Benjamin V. Stone, Charles Maynard, Ross G. Gerrity (+ more)
2009
Atherosclerosis
doi:10.1016/j.atherosclerosis.2008.07.032
pmcid:PMC4637934
pmid:18786669
|
web.archive.org [PDF]
|
[CR19]
via crossref
|
Upregulation of lectinlike oxidized low-density lipoprotein receptor-1 expression contributes to the vein graft atherosclerosis: modulation by losartan
Junbo Ge, Dong Huang, Chun Liang, Yukun Luo, Qingzhe Jia, Keqiang Wang
2004
Atherosclerosis
doi:10.1016/j.atherosclerosis.2004.07.021
pmid:15530898
|
|
[CR20]
via crossref
|
Decreased infiltration of macrophages and inhibited activation of nuclear factor-kappa B in blood vessels: a possible mechanism for the anti-atherogenic effects of losartan
H-X. Xu, J-J. Li, G-S. Li, J. Wang, N-X. Li, J. Peng
2007
Acta Cardiologica
doi:10.2143/ac.62.6.2024021
pmid:18214127
|
|
[CR21]
via crossref
|
Effects of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Antagonist Combination on Nitric Oxide Bioavailability and Atherosclerotic Change in Watanabe Heritable Hyperlipidemic Rabbits
Toshio IMANISHI, Akio KUROI, Hideyuki IKEJIMA, Katsunobu KOBAYASHI, Yasuteru MURAGAKI, Seiichi MOCHIZUKI, Masami GOTO, Kiyoshi YOSHIDA (+ more)
2008
Hypertension Research
doi:10.1291/hypres.31.575
pmid:18497479
|
web.archive.org [PDF]
|
[CR22]
via crossref
|
Molecular Dissection of Angiotensin II-Activated Human LOX-1 Promoter
J. Chen
2006
Arteriosclerosis, Thrombosis and Vascular Biology
doi:10.1161/01.atv.0000209998.73303.b5
pmid:16484599
|
web.archive.org [PDF]
|
[CR23]
via crossref
|
Molecular Mechanisms Involved in Atherosclerosis
Muhidien Soufi, Alexander M. Sattler, Bernhard Maisch, Jürgen R. Schaefer
2002
Herz
doi:10.1007/s00059-002-2431-2
pmid:12439635
|
|
[b23]
via grobid
|
Soufi M, Sattler AM, Maisch B, Schaefer JR. Molecular mechanisms involved in atherosclerosis. Herz 2002; 27: 637-48.
|
|